still digesting your awesome article. My friend, who works in hi tech with Brazilian engineers, told me Facebook is invested heavily in Brain Machine Interface tech down there. Not sure if it's in the same lane as your info, but most likely it is.
This article is very smart but it deals with things that I difficult to pinpoint exactly. There is however definitely enough reasons to be concerned and to need to stay informed as well
".... his team has been able to replicate international findings that HEPARIN can block the transmission of COVID-19 and prevent infection.
The spray coats the nose but does not go down into the lungs. The researchers say it is cheap, easy to distribute and is expected to be effective against mutant strains of the virus including the Omicron variant.
"It won't matter if a new variant comes along, this drug will block that protein from infecting the cells," Professor Campbell said.
"I'm very confident that we can demonstrate that it will work, and people will be using this before they go to the shops and before they go to school."
The world really feels like a nightmare lately. 😩
still digesting your awesome article. My friend, who works in hi tech with Brazilian engineers, told me Facebook is invested heavily in Brain Machine Interface tech down there. Not sure if it's in the same lane as your info, but most likely it is.
Very creepy!
In (1.), the "minimal chronic immune response in the brain" gave me a hearty laugh. Chronic, yet minimal. Or perhaps, minimal but chronic?
This article is very smart but it deals with things that I difficult to pinpoint exactly. There is however definitely enough reasons to be concerned and to need to stay informed as well
Somewhat off-topic, but it is important:
".... his team has been able to replicate international findings that HEPARIN can block the transmission of COVID-19 and prevent infection.
The spray coats the nose but does not go down into the lungs. The researchers say it is cheap, easy to distribute and is expected to be effective against mutant strains of the virus including the Omicron variant.
"It won't matter if a new variant comes along, this drug will block that protein from infecting the cells," Professor Campbell said.
"I'm very confident that we can demonstrate that it will work, and people will be using this before they go to the shops and before they go to school."
https://www.abc.net.au/news/2021-12-22/melbourne-researchers-trial-use-of-common-drug-to-combat-covid/100717224